137 related articles for article (PubMed ID: 33587450)
1. mTOR Pathway Activation Assessed by Immunohistochemistry in Cervical Biopsies of HPV-associated Endocervical Adenocarcinomas (HPVA): Correlation With Silva Invasion Patterns.
Segura S; Stolnicu S; Boros M; Park K; Ramirez P; Salvo G; Frosina D; Jungbluth A; Soslow RA
Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):527-533. PubMed ID: 33587450
[TBL] [Abstract][Full Text] [Related]
2. Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Pike MC; Soslow RA
Gynecol Oncol; 2018 Jul; 150(1):56-60. PubMed ID: 29859673
[TBL] [Abstract][Full Text] [Related]
3. Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.
Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
[TBL] [Abstract][Full Text] [Related]
5. Molecular correlates of invasion pattern in HPV-associated endocervical adenocarcinoma: emergence of two distinct risk-stratified tiers.
Sharma AE; Hodgson AJ; Howitt BE; Olkhov-Mitsel E; Djordevic B; Park KJ; Nucci MR; Parra-Herran C
Histopathology; 2023 Jun; 82(7):1067-1078. PubMed ID: 36849702
[TBL] [Abstract][Full Text] [Related]
6. Application of a Pattern-based Classification System for Invasive Endocervical Adenocarcinoma in Cervical Biopsy, Cone and Loop Electrosurgical Excision (LEEP) Material: Pattern on Cone and LEEP is Predictive of Pattern in the Overall Tumor.
Djordjevic B; Parra-Herran C
Int J Gynecol Pathol; 2016 Sep; 35(5):456-66. PubMed ID: 26630232
[TBL] [Abstract][Full Text] [Related]
7. Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
Neil AJ; Li YY; Hakam A; Nucci MR; Parra-Herran C
Histopathology; 2024 Jan; 84(2):369-380. PubMed ID: 37920148
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system.
Stolnicu S; Hoang L; Almadani N; De Brot L; Baiocchi G; Bovolim G; Brito MJ; Karpathiou G; Ieni A; Guerra E; Kiyokawa T; Dundr P; Parra-Herran C; Lérias S; Felix A; Roma A; Pesci A; Oliva E; Park KJ; Soslow RA; Abu-Rustum NR
Pathology; 2022 Aug; 54(5):548-554. PubMed ID: 35501168
[TBL] [Abstract][Full Text] [Related]
9. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
[TBL] [Abstract][Full Text] [Related]
10. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
11. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
Park KJ
Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
[TBL] [Abstract][Full Text] [Related]
12. Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance.
Park KJ; Cabrero IA; Fadare O; Hoang L; Kiyokawa T; Oliva E; Parra-Herran C; Rabban JT; Roma A; Singh N; Soslow R; Stolnicu S; Huvila J; Leung S; Gilks CB
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S14-S23. PubMed ID: 33570861
[TBL] [Abstract][Full Text] [Related]
13. Cervical Adenocarcinoma: Histopathologic Features From Biopsies to Predict Tumor Behavior.
Rivera-Colon G; Chen H; Niu S; Lucas E; Holloway S; Carrick K; Gwin K; Lea J; Zheng W
Am J Surg Pathol; 2020 Feb; 44(2):247-254. PubMed ID: 31567190
[TBL] [Abstract][Full Text] [Related]
14. International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.
Ren H; Almadani N; Pors J; Leung S; Ho J; Chow C; Ta M; Park KJ; Stolnicu S; Soslow R; Huntsman D; Gilks BC; Hoang L
Int J Gynecol Pathol; 2021 Nov; 40(6):533-540. PubMed ID: 34612210
[TBL] [Abstract][Full Text] [Related]
15. International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.
Hodgson A; Olkhov-Mitsel E; Howitt BE; Nucci MR; Parra-Herran C
J Clin Pathol; 2019 May; 72(5):347-353. PubMed ID: 30679193
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma.
Zhou F; Chen H; Li M; Strickland AL; Zheng W; Zhang X
Am J Surg Pathol; 2022 Mar; 46(3):300-308. PubMed ID: 35175967
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in invasive adenocarcinoma of the cervix.
Stolnicu S; Hoang L; Soslow RA
Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas.
Staebler A; Sherman ME; Zaino RJ; Ronnett BM
Am J Surg Pathol; 2002 Aug; 26(8):998-1006. PubMed ID: 12170086
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract][Full Text] [Related]
20. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]